Please check your internet connection and try again.
# Ezivac enema
## Overview
Ezivac enema is a hyperosmotic laxative, typically containing sodium phosphate. It works by drawing water into the bowel lumen to soften stool and stimulate bowel movement.
## Primary Indications
Constipation. Bowel preparation prior to endoscopic or radiological procedures.
## Adult Dosing
* **Constipation:** Typically 1 single-dose enema (118 mL) administered rectally. Onset of action is usually within 2-5 minutes.
* **Bowel Preparation:** Specific dosing may vary based on procedural guidelines. Often, a single enema is administered.
## Pediatric Dosing
Safety and efficacy have not been established for children under 12 years of age. Use in this population is not recommended.
## Dose Adjustments
No dose adjustments are typically required based on renal or hepatic impairment, but caution is advised in patients with severe impairment due to potential for electrolyte disturbances.
## Contraindications
* Congestive heart failure
* Intestinal obstruction
* Severe renal impairment (creatinine clearance <30 mL/min)
* Congenital megacolon
* Ileus
* Patients on medications that prolong the QT interval
* Children under 12 years of age
* Hypersensitivity to sodium phosphate
* Known or suspected abdominal conditions (e.g., appendicitis, toxic megacolon, perforation)
## Adverse Effects
* **Common:** Abdominal cramping, nausea, vomiting, rectal irritation, diarrhea.
* **Serious:** Electrolyte disturbances (hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia), dehydration, renal damage, cardiac arrhythmias, seizures.
## Key Drug Interactions
* **Diuretics (loop, thiazide) and antihypertensives:** Increased risk of electrolyte imbalance and dehydration.
* **Medications affecting gut motility:** May alter absorption or efficacy.
* **Calcium or magnesium-containing antacids:** May increase risk of hypermagnesemia or hypercalcemia.
* **Medications prolonging QT interval:** Increased risk of cardiac arrhythmias if systemic absorption occurs.
## Monitoring
* Monitor for signs and symptoms of dehydration and electrolyte imbalance (e.g., dizziness, confusion, muscle weakness, palpitations).
* Assess bowel function and stool output.
* In patients with risk factors, consider monitoring serum electrolytes and renal function.
## Clinical Pearls
* Administer slowly and retain if possible.
* Avoid frequent or prolonged use to prevent dependence and electrolyte disturbances.
* Educate patients on proper administration technique and potential adverse effects.
* Ensure adequate fluid intake, especially in elderly or debilitated patients.
* Use with extreme caution in patients with impaired renal function or underlying cardiac conditions.
**Disclaimer:** This information is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified healthcare provider to ensure the information is current and relevant to your specific situation. Verify current prescribing information before making any treatment decisions.
